Beauty Health Co (SKIN) Stock Forecast & Price Target
Beauty Health Co · NASDAQ
$0.69-0.06 (-7.61%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Beauty Health Co, 1 rate it Buy or better, 4 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets range widely, $1.00 to $2.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $1.53 sits 122% above the current $0.69. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.05 next quarter toward $0.15 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy00%
Buy120%
Hold480%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Beauty Health Co.
As of Jul, 1 of 5 firms rate SKIN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SKIN EPS & revenue forecast
EPS · NEXT QUARTER
$-0.05
Range $-0.08 – $-0.02 · 7 analysts · -42% YoY
Next period, 7 analysts expect Beauty Health Co to earn $-0.05 a share (range $-0.08 – $-0.02), versus $-0.09 a year earlier. Full-year consensus is $0.11, growing to $0.15 the year after.
REVENUE · NEXT QUARTER
$69.5M
Range $67.8M – $71.7M · 7 analysts · -2% YoY
Revenue is expected to reach $69.5M (range $67.8M – $71.7M), -1.6% year-over-year. Full-year consensus is $290.5M, rising to $305.3M next year.
Top analysts covering Beauty Health Co
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SKIN.
#1
Jonathan Block
Stifel · Rank #172
Hold
$2.00+189.4% to target
Overall win rate
42%
+ Follow
#2
George Kelly
Roth MKM · Rank #185
Buy
$2.00+189.4% to target
Overall win rate
43%
+ Follow
#3
Bruce Jackson
Benchmark · Rank #317
Hold
No targeton SKIN
Overall win rate
35%
+ Follow
#4
Susan Anderson
Canaccord Genuity · Rank #352
Hold
$1.00+44.7% to target
Overall win rate
27%
+ Follow
#5
SW
Sydney Wagner
Jefferies
Hold
$1.60+131.5% to target
Coverage
—
+ Follow
SKIN stock forecast FAQ
What is SKIN's average 12-month price target?+
The 3 analysts with a live target average $1.53 for Beauty Health Co over the next 12 months, ranging from a $2.00 high to a $1.00 low.
Is SKIN stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 1 are Buy or Strong Buy, 4 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SKIN?+
The Street-high target is $2.00 (Roth Capital), and the Street-low is $1.00 (Canaccord Genuity). The average of all 3 active targets is $1.53.
How many Wall Street analysts cover SKIN?+
5 analysts have an active rating on Beauty Health Co, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering SKIN?+
Among analysts who currently cover SKIN, Jonathan Block of Stifel has the strongest overall Quantellect track record (Rank #172). Their current call is Hold with a $2.00 target.
What is Beauty Health Co's projected EPS for next quarter?+
The consensus estimate is $-0.05 per share (range $-0.08 – $-0.02) across 7 analysts. Full-year EPS is projected at $0.11, rising to $0.15 the following year.
How much revenue is Beauty Health Co expected to report next quarter?+
Consensus revenue is $69.5M (range $67.8M – $71.7M). Full-year revenue is projected at $290.5M, growing to $305.3M next year.
Have analysts been upgrading or downgrading SKIN lately?+
As of Jul, 1 of 5 firms rate SKIN a Buy (4 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SKIN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
